Sector revisions Gilead Sciences, Inc. Mexican S.E.

Stocks

End-of-day quote Mexican S.E. Other stock markets 2026-07-30			5-day change	1st Jan Change
2,301.25 ^MXN	+1.15%		+1.15%	+3.55%

08-03	California's highest court rules for Gilead in 'duty to innovate' case	RE
08-03	Falling Oil Boosts Wall Street Pre-Bell; Asia Mixed, Europe Up	MT

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	1m. Revenue rev.	4m. EPS revision	4m. Revenue rev.	1y. EPS revision	1y. Revenue rev.	Visibility	Nbr of analysts
	ELI LILLY AND COMPANY							26
	JOHNSON & JOHNSON							22
	ABBVIE INC.							28
	ROCHE HOLDING AG							18
	NOVARTIS AG							21
	ASTRAZENECA PLC							22
	NOVO NORDISK A/S							24
	AMGEN INC.							29
	PFIZER INC.							26
	BRISTOL-MYERS SQUIBB COMPANY							23
	VERTEX PHARMACEUTICALS INCORPORATED							24
	GSK PLC							20
	SANOFI							23
	CHUGAI PHARMACEUTICAL CO., LTD.							15
	TAKEDA PHARMACEUTICAL COMPANY LIMITED							16
	BAYER AG							18
	JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD							15
	HALEON PLC							17
	TEVA PHARMACEUTICAL INDUSTRIES LIMITED							10
	Average							21
	Weighted average by Cap.							23